Sanofi Aventis Korea said Wednesday it has appointed as its research development director, Choi Ju-yeon, a world-renowned expert in developing new drugs.
Choi will take charge of reinforcing open innovation and partnership strategy through a decentralized and non-authoritative R&D organization and also focusing on translational medicine.
“Previously at LG Life Sciences, he has spearheade...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.